Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.
N Engl J Med
; 385(13): 1196-1206, 2021 09 23.
Article
in En
| MEDLINE
| ID: mdl-34551229
Full text:
1
Database:
MEDLINE
Main subject:
Uveal Neoplasms
/
Recombinant Fusion Proteins
/
Melanoma
/
Antineoplastic Agents
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
N Engl J Med
Year:
2021
Type:
Article